Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Affiliations

Gene Therapy Shown to Prevent, Reverse Multiple Sclerosis

Medical researchers show that transferring healthy genes can protect nerve cells in lab mice against damage from multiple sclerosis, and help reverse effects of the disease. . . . → Read More: Gene Therapy Shown to Prevent, Reverse Multiple Sclerosis

Patent Awarded for Live Bacterial Acne Treatment

A company developing treatments for disease by restoring the natural balance of bacteria on the skin received a patent for its acne therapy using spray-on live bacteria. . . . → Read More: Patent Awarded for Live Bacterial Acne Treatment

Guidelines Designed for CAR T-Cell Cancer Therapies

Cancer specialists and scientists at several cancer care centers propose safety guidelines for patients receiving engineered immune cell treatments that often have severe adverse effects. . . . → Read More: Guidelines Designed for CAR T-Cell Cancer Therapies

Neuro Disease Start-Up Gains $30M in Early Funds

A start-up enterprise developing treatments for several neurological diseases that the company says are triggered by a common destructive protein, is raising $30 million its first venture financing round. . . . → Read More: Neuro Disease Start-Up Gains $30M in Early Funds

Avian Flu Vaccine with Longer Protection in Development

A biotechnology company is designing a vaccine to protect against the newly emergent avian flu to provide more sustained protection like seasonal flu vaccines. . . . → Read More: Avian Flu Vaccine with Longer Protection in Development

Drug Delivery Technology Licensed in $2B Deals

The biotechnology company Halozyme Therapeutics Inc. is licensing its technology for making infusion drugs deliverable with injections to two more drug makers. . . . → Read More: Drug Delivery Technology Licensed in $2B Deals

Trial Shows Antibody Effective Against Asthma

Results from a large-scale clinical trial show a synthetic antibody, when added to standard treatments, reduces asthma attacks and improves lung functioning. . . . → Read More: Trial Shows Antibody Effective Against Asthma

NIH Funds Heart Tissue Regeneration Tests in Pigs

An experimental drug to help grow new heart tissue after a heart attack is advancing to tests in pigs, with help from National Institutes of Health. . . . → Read More: NIH Funds Heart Tissue Regeneration Tests in Pigs

Start-Up Lands $10M for Gene-Editing HIV Treatments

A new enterprise developing treatments using gene editing to eliminate HIV infections received $10 million in its seed funding round. . . . → Read More: Start-Up Lands $10M for Gene-Editing HIV Treatments

Engineered T-Cell Trials Stopped after Patient Death

The Food and Drug Administration stopped two clinical trials testing genetically engineered T-cells from the immune system to treat leukemia, after a participant in one trial died. . . . → Read More: Engineered T-Cell Trials Stopped after Patient Death